News

Quintiles and SAS are developing a unique program to produce certified specialists in the use of SAS programming to evaluate clinical trials results.

Jubilant Organosys Ltd. announced today that its subsidiary Clinsys Clinical Research, Inc., New Jersey, a global contract research organization (CRO), has acquired TrialStat ClinicalAnalytics from TrialStat for a purchase consideration of CAD 750,000.

ICON plc today announced that it has signed an agreement with Eli Lilly and Company to manage the company's clinical data management business outside the United States.

DIA, the multidisciplinary, non-profit association that provides a neutral forum for the exchange of information critical to the advancement of the drug discovery and life cycle management processes, has opened an office in Beijing, China.

Octagon Research Solutions Inc. has been named to Deloitte?s prestigious Fast 50 Program for Greater Philadelphia, a ranking of the 50 fastest growing technology, media, telecommunications and life sciences companies in the area by Deloitte LLP, one of the nation?s leading professional services organizations.

Bioanalytical Systems, Inc announced today that Anthony S. Chilton, Ph.D. is joining the Company as Chief Operating Officer, Scientific Services, effective December 1, 2008.

Abingdon Life Sciences and Stason Pharmaceuticals have extended their strategic alliance, which was originally announced on August 4th 2008.

ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology, and medical device industries, today announced that is has acquired Prevalere Life Sciences Inc., a wholly owned subsidiary of ORS Labs Inc.

Synexus is planning to more than double its clinical trial capacity in South Africa through the expansion of its Pretoria facilities and by opening two purposed designed sites, one in Mamelodi and one in Soshanguwe.

Octagon Research Solutions, Inc. has been ranked number 417 among the fastest growing companies in North America on Deloitte?s 2008 Technology Fast 500.

Mayo Clinic leadership made the decision to discontinue the sales and marketing efforts of Mayo Clinic Trial Services.

Biotrial, a full-service CRO and European leader in drug evaluation and pharmacology research, appoints new Head to manage its growing data management activity.

Biotrial today announced the continued strengthening of its medical team with a key appointment.

DIA's 3rd Annual Cardiac Safety Conference being held in Barcelona, Spain on December 4, 2008.

To meet market demands for global trials, ICON plc, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the opening of a full service central laboratory in Bangalore, India.

Patheon, a global provider of drug development and manufacturing services to the international pharmaceutical industry, will launch its recently enhanced Quick To Clinic(SM) program at the 2008 AAPS Annual Conference in Atlanta, Georgia.

PPD, Inc. today announced that its board of directors declared a cash dividend for the fourth quarter of 2008 under its annual cash dividend policy.

ACORN a CRO focused on oncology, announced today that its third quarter had once again exceeded projections as the company continues to experience banner growth.

The Institute of Clinical Research (ICR) has announced a specialist insurance and professional indemnity deal exclusively for its members.

Pharmaceutical Profiles delivers critical ivPK data in early drug development.

Octagon Research, a provider of software and services to the life sciences industry, today announced the release of a global document authoring template suite.

D. Anderson & Company (DAC), a global leader in patient recruitment and retention, has been named one of the 50 Largest Women-Owned Businesses in Dallas-Ft. Worth for 2008.

DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today reported its operating results for the third quarter and first nine months of 2008.

PAREXEL International Corporation, a global biopharmaceutical services provider, today announced that the Company is among the first to conduct a Chinese bridging study outside of China.

The European Union's efforts in combating rare diseases reached a new milestone this October, with the 50th positive opinion on an 'orphan' medicine being adopted by the EMEA's Committee for Medicinal Products for Human Use (CHMP).

Octagon has released a new process management platform that provides foundation for data, document, and submission management.

Patheon, a global provider of drug development and manufacturing services to the international pharmaceutical industry, today announced the opening of its new headquarters for its European operations in Zug, Switzerland, near Zurich.

Drug Information Association (DIA) is conducting an event called 9th Conference on European Electronic Document Management which will be held from 03rd December 2008 in Barcelona, Spain.

Drug Information Association (DIA) is conducting an event called European Regulatory Affairs Forum which will be held from 24th November 2008 in Munich, Germany.